RGCVSROIV• 3 Months (Normalized)
RGC vs ROIV (Regencell Bioscience Holdings Limited vs Roivant Sciences Ltd.)
Showing Closing Date Range from Jun, 20 to Sep, 18, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
RGC Performance $5.79
-44.91%
Regencell Bioscience Holdings Limited
Normalized Baseline0.00%
ROIV Performance $39.77
+27.26%
Roivant Sciences Ltd.
Normalized Baseline0.00%
Alpha Spread Margin ROIV LEADS
-72.17%
ROIV outperforming by 72.17%
RGCROIV
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
RGC ROIV
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | RGC Price | RGC Gain (%) | ROIV Price | ROIV Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 18, 2026 | $5.79 | -44.91% | $39.77 | +27.26% | -72.17% |
| Sep 17, 2026 | $5.96 | -43.29% | $39.98 | +27.94% | -71.23% |
| Sep 16, 2026 | $5.68 | -45.96% | $39.57 | +26.62% | -72.58% |
| Sep 15, 2026 | $5.60 | -46.72% | $39.50 | +26.40% | -73.12% |
| Sep 14, 2026 | $5.74 | -45.39% | $41.02 | +31.26% | -76.65% |
| Sep 11, 2026 | $5.64 | -46.34% | $40.82 | +30.62% | -76.96% |
| Sep 10, 2026 | $5.64 | -46.38% | $40.94 | +31.01% | -77.39% |
| Sep 09, 2026 | $5.85 | -44.34% | $41.81 | +33.79% | -78.13% |
| Sep 08, 2026 | $6.82 | -35.11% | $41.48 | +32.74% | -67.85% |
| Sep 04, 2026 | $6.89 | -34.44% | $34.93 | +11.78% | -46.22% |
| Sep 03, 2026 | $6.48 | -38.34% | $34.41 | +10.11% | -48.45% |
| Sep 02, 2026 | $6.31 | -39.96% | $34.18 | +9.38% | -49.34% |
| Sep 01, 2026 | $5.50 | -47.67% | $34.52 | +10.46% | -58.13% |
| Aug 31, 2026 | $5.51 | -47.57% | $34.64 | +10.85% | -58.42% |
| Aug 28, 2026 | $5.50 | -47.67% | $34.71 | +11.07% | -58.74% |
Page 1 of 5